§ BIOTECHNOLOGY
USD · BiotechnologyZNTL
ZENTALIS PHARMACEUTICALS INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
65 increased/new, 34 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| 5AM Venture Management, LLC | 3.9M | 2.6% | ±0% |
| Squadron Capital Management LLC | 3.6M | 3.1% | n/a |
| TWO SIGMA INVESTMENTS, LP | 3.0M | 0.0% | +101% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | n/a | n/a |
| Renaissance Technologies | 1.9M | 0.0% | −33% |
| Citadel Advisors | 1.7M | 0.0% | −12% |
◇ AC INTELLIGENCE
Top institutional owners for ZNTL as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER35.4% · 0 holders
OTHER44.6% · 70 holders
DEALER / BANK5.2% · 12 holders
TACTICAL / MACRO4.4% · 4 holders
SYSTEMATIC / QUANT3.3% · 5 holders
PASSIVE / INDEX2.9% · 4 holders
QUALITY / COMPOUNDER2.3% · 5 holders
ACTIVIST2.1% · 1 holder
INCOME / DEFENSIVE0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ZNTL in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention ZNTL yet.